141P Circulating immune cells predict immunotherapy benefit in patients with triple negative breast cancer: Preliminary results from the IRIS study.

Saved in:
Bibliographic Details
Title: 141P Circulating immune cells predict immunotherapy benefit in patients with triple negative breast cancer: Preliminary results from the IRIS study.
Authors: Conte, B.1 (AUTHOR), Martini, V.2 (AUTHOR), Alsati, R.3 (AUTHOR), Boldorini, R.4 (AUTHOR), Gobbato, S.5 (AUTHOR), Negrini, L.6 (AUTHOR), Ben Ayed, R.7 (AUTHOR), Ruffilli, B.8 (AUTHOR), Vezzoli, F.8 (AUTHOR), Sala, N.9 (AUTHOR), Matera, L.10 (AUTHOR), Branni, C.8 (AUTHOR), Rossi, V.8 (AUTHOR), Taglialatela, I.11 (AUTHOR), D'Avanzo, F.12 (AUTHOR), Gennari, A.1 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS271-S272. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.149